ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma.

Joseph M Tuscano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.